Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 12 entries
Sorted by: Best Match Show Resources per page
Imposter Syndrome in Surgical Trainees: Clance Imposter Phenomenon Scale Assessment in General Surgery Residents.

Journal of the American College of Surgeons

Bhama AR, Ritz EM, Anand RJ, Auyang ED, Lipman J, Greenberg JA, Kapadia MR.
PMID: 34384871
J Am Coll Surg. 2021 Nov;233(5):633-638. doi: 10.1016/j.jamcollsurg.2021.07.681. Epub 2021 Aug 09.

BACKGROUND: Imposter syndrome occurs when high-achieving individuals have a pervasive sense of self-doubt combined with fear of being exposed as a fraud, despite objective measures of success. This threatens mental health and well-being. The prevalence and severity of imposter...

Cite
Bhama AR, Ritz EM, Anand RJ, et al. Imposter Syndrome in Surgical Trainees: Clance Imposter Phenomenon Scale Assessment in General Surgery Residents. J Am Coll Surg. 2021;233(5):633-638doi: 10.1016/j.jamcollsurg.2021.07.681.
Bhama, A. R., Ritz, E. M., Anand, R. J., Auyang, E. D., Lipman, J., Greenberg, J. A., & Kapadia, M. R. (2021). Imposter Syndrome in Surgical Trainees: Clance Imposter Phenomenon Scale Assessment in General Surgery Residents. Journal of the American College of Surgeons, 233(5), 633-638. https://doi.org/10.1016/j.jamcollsurg.2021.07.681
Bhama, Anuradha R, et al. "Imposter Syndrome in Surgical Trainees: Clance Imposter Phenomenon Scale Assessment in General Surgery Residents." Journal of the American College of Surgeons vol. 233,5 (2021): 633-638. doi: https://doi.org/10.1016/j.jamcollsurg.2021.07.681
Bhama AR, Ritz EM, Anand RJ, Auyang ED, Lipman J, Greenberg JA, Kapadia MR. Imposter Syndrome in Surgical Trainees: Clance Imposter Phenomenon Scale Assessment in General Surgery Residents. J Am Coll Surg. 2021 Nov;233(5):633-638. doi: 10.1016/j.jamcollsurg.2021.07.681. Epub 2021 Aug 09. PMID: 34384871.
Copy Download .nbib Format: NLM
Understanding Opioid Prescribing Practices of Resident Physicians.

The American surgeon

Coughlin JM, Terranella SL, Ritz EM, Xu TQ, Tierney JF, Velasco JM, Myers JA.
PMID: 34971336
Am Surg. 2021 Dec 31;31348211060412. doi: 10.1177/00031348211060412. Epub 2021 Dec 31.

BACKGROUND: To compare opioid prescribing practices of resident physicians across a variety of surgical and nonsurgical specialties; to identify factors which influence prescribing practices; and to examine resident utilization of best practice supplemental resources.METHODS: An anonymous survey which assessed...

Cite
Coughlin JM, Terranella SL, Ritz EM, et al. Understanding Opioid Prescribing Practices of Resident Physicians. Am Surg. 2021;31348211060412doi: 10.1177/00031348211060412.
Coughlin, J. M., Terranella, S. L., Ritz, E. M., Xu, T. Q., Tierney, J. F., Velasco, J. M., & Myers, J. A. (2021). Understanding Opioid Prescribing Practices of Resident Physicians. The American surgeon, 31348211060412. https://doi.org/10.1177/00031348211060412
Coughlin, Julia M, et al. "Understanding Opioid Prescribing Practices of Resident Physicians." The American surgeon vol. (2021): 31348211060412. doi: https://doi.org/10.1177/00031348211060412
Coughlin JM, Terranella SL, Ritz EM, Xu TQ, Tierney JF, Velasco JM, Myers JA. Understanding Opioid Prescribing Practices of Resident Physicians. Am Surg. 2021 Dec 31;31348211060412. doi: 10.1177/00031348211060412. Epub 2021 Dec 31. PMID: 34971336.
Copy Download .nbib Format: NLM
Patient Race and Insurance Status Do Not Impact the Treatment of Simple Mandibular Fractures.

Craniomaxillofacial trauma & reconstruction

Xu TQ, Wiegmann AL, Jarazcewski TJ, Ritz EM, Santos CAQ, Dorafshar AH.
PMID: 32642027
Craniomaxillofac Trauma Reconstr. 2020 Mar;13(1):15-22. doi: 10.1177/1943387520905399. Epub 2020 Mar 04.

INTRODUCTION: Health-care disparities have been reported throughout medical literature for decades. While blatant explicit bias is not prevalent, a substantial body of research has been published suggesting that systemic biases related to sex, race, income, and insurance status likely...

Cite
Xu TQ, Wiegmann AL, Jarazcewski TJ, et al. Patient Race and Insurance Status Do Not Impact the Treatment of Simple Mandibular Fractures. Craniomaxillofac Trauma Reconstr. 2020;13(1):15-22doi: 10.1177/1943387520905399.
Xu, T. Q., Wiegmann, A. L., Jarazcewski, T. J., Ritz, E. M., Santos, C. A. Q., & Dorafshar, A. H. (2020). Patient Race and Insurance Status Do Not Impact the Treatment of Simple Mandibular Fractures. Craniomaxillofacial trauma & reconstruction, 13(1), 15-22. https://doi.org/10.1177/1943387520905399
Xu, Thomas Q, et al. "Patient Race and Insurance Status Do Not Impact the Treatment of Simple Mandibular Fractures." Craniomaxillofacial trauma & reconstruction vol. 13,1 (2020): 15-22. doi: https://doi.org/10.1177/1943387520905399
Xu TQ, Wiegmann AL, Jarazcewski TJ, Ritz EM, Santos CAQ, Dorafshar AH. Patient Race and Insurance Status Do Not Impact the Treatment of Simple Mandibular Fractures. Craniomaxillofac Trauma Reconstr. 2020 Mar;13(1):15-22. doi: 10.1177/1943387520905399. Epub 2020 Mar 04. PMID: 32642027; PMCID: PMC7311844.
Copy Download .nbib Format: NLM
A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency.

International journal of pediatric endocrinology

Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC.
PMID: 20981249
Int J Pediatr Endocrinol. 2010;2010:494173. doi: 10.1155/2010/494173. Epub 2010 Jun 30.

Steroid 21-hydroxylase deficiency accounts for about 95% of cases of congenital adrenal hyperplasia (CAH). Newborns are currently being screened for the classical forms of this disease throughout the United States and in 12 other countries. As such, it seems...

Cite
Speiser PW, Azziz R, Baskin LS, et al. A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency. Int J Pediatr Endocrinol. 2010;2010:494173doi: 10.1155/2010/494173.
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F., Miller, W. L., Montori, V. M., Oberfield, S. E., Ritzen, M., & White, P. C. (2010). A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency. International journal of pediatric endocrinology, 2010494173. https://doi.org/10.1155/2010/494173
Speiser, Phyllis W, et al. "A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency." International journal of pediatric endocrinology vol. 2010 (2010): 494173. doi: https://doi.org/10.1155/2010/494173
Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC. A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency. Int J Pediatr Endocrinol. 2010;2010:494173. doi: 10.1155/2010/494173. Epub 2010 Jun 30. PMID: 20981249; PMCID: PMC2963799.
Copy Download .nbib Format: NLM
Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy.

Cancers

Yun NK, Rouhani SJ, Bestvina CM, Ritz EM, Gilmore BA, Tarhoni I, Borgia JA, Batus M, Bonomi PD, Fidler MJ.
PMID: 33804721
Cancers (Basel). 2021 Mar 20;13(6). doi: 10.3390/cancers13061426.

BACKGROUND: First-line treatment for patients with non-small cell lung cancer (NSCLC) with a sensitizing epidermal growth factor receptor (METHODS: This study is a retrospective review of 137 patients with advanced RESULTS: On univariable analysis, NLR ≥ 5 or higher...

Cite
Yun NK, Rouhani SJ, Bestvina CM, et al. Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy. Cancers (Basel). 2021;13(6)doi: 10.3390/cancers13061426.
Yun, N. K., Rouhani, S. J., Bestvina, C. M., Ritz, E. M., Gilmore, B. A., Tarhoni, I., Borgia, J. A., Batus, M., Bonomi, P. D., & Fidler, M. J. (2021). Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy. Cancers, 13(6), . https://doi.org/10.3390/cancers13061426
Yun, Nicole K, et al. "Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy." Cancers vol. 13,6 (2021). doi: https://doi.org/10.3390/cancers13061426
Yun NK, Rouhani SJ, Bestvina CM, Ritz EM, Gilmore BA, Tarhoni I, Borgia JA, Batus M, Bonomi PD, Fidler MJ. Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy. Cancers (Basel). 2021 Mar 20;13(6). doi: 10.3390/cancers13061426. PMID: 33804721; PMCID: PMC8003851.
Copy Download .nbib Format: NLM
Voice-related quality of life: Relation to objective spirometry measures in subglottic stenosis.

American journal of otolaryngology

Eggerstedt M, Kim YJ, Ritz EM, Patel TR, Theis SM, Husain IA.
PMID: 33838356
Am J Otolaryngol. 2021 Sep-Oct;42(5):103013. doi: 10.1016/j.amjoto.2021.103013. Epub 2021 Mar 30.

OBJECTIVES: The current study seeks to identify the correlation between in-office spirometry data and voice-related quality of life in patients with subglottic stenosis (SGS).METHODS: Patients with SGS of any etiology were included when in-office spirometric data was available in...

Cite
Eggerstedt M, Kim YJ, Ritz EM, et al. Voice-related quality of life: Relation to objective spirometry measures in subglottic stenosis. Am J Otolaryngol. 2021;42(5):103013doi: 10.1016/j.amjoto.2021.103013.
Eggerstedt, M., Kim, Y. J., Ritz, E. M., Patel, T. R., Theis, S. M., & Husain, I. A. (2021). Voice-related quality of life: Relation to objective spirometry measures in subglottic stenosis. American journal of otolaryngology, 42(5), 103013. https://doi.org/10.1016/j.amjoto.2021.103013
Eggerstedt, Michael, et al. "Voice-related quality of life: Relation to objective spirometry measures in subglottic stenosis." American journal of otolaryngology vol. 42,5 (2021): 103013. doi: https://doi.org/10.1016/j.amjoto.2021.103013
Eggerstedt M, Kim YJ, Ritz EM, Patel TR, Theis SM, Husain IA. Voice-related quality of life: Relation to objective spirometry measures in subglottic stenosis. Am J Otolaryngol. 2021 Sep-Oct;42(5):103013. doi: 10.1016/j.amjoto.2021.103013. Epub 2021 Mar 30. PMID: 33838356.
Copy Download .nbib Format: NLM
Prediction of Chameleonic Efficiency.

ChemMedChem

David L, Wenlock M, Barton P, Ritzén A.
PMID: 34240561
ChemMedChem. 2021 Sep 06;16(17):2669-2685. doi: 10.1002/cmdc.202100306. Epub 2021 Aug 04.

Chameleonic properties, i. e., the capacity of a molecule to hide polarity in non-polar environments and expose it in water, help achieving sufficient permeability and solubility for drug molecules with high MW. We present models of experimental measures of...

Cite
David L, Wenlock M, Barton P, et al. Prediction of Chameleonic Efficiency. ChemMedChem. 2021;16(17):2669-2685doi: 10.1002/cmdc.202100306.
David, L., Wenlock, M., Barton, P., & Ritzén, A. (2021). Prediction of Chameleonic Efficiency. ChemMedChem, 16(17), 2669-2685. https://doi.org/10.1002/cmdc.202100306
David, Laurent, et al. "Prediction of Chameleonic Efficiency." ChemMedChem vol. 16,17 (2021): 2669-2685. doi: https://doi.org/10.1002/cmdc.202100306
David L, Wenlock M, Barton P, Ritzén A. Prediction of Chameleonic Efficiency. ChemMedChem. 2021 Sep 06;16(17):2669-2685. doi: 10.1002/cmdc.202100306. Epub 2021 Aug 04. PMID: 34240561.
Copy Download .nbib Format: NLM
Fragment-Based Discovery of 6-Arylindazole JAK Inhibitors.

ACS medicinal chemistry letters

Ritzén A, Sørensen MD, Dack KN, Greve DR, Jerre A, Carnerup MA, Rytved KA, Bagger-Bahnsen J.
PMID: 27326341
ACS Med Chem Lett. 2016 Apr 14;7(6):641-6. doi: 10.1021/acsmedchemlett.6b00087. eCollection 2016 Jun 09.

Janus kinase (JAK) inhibitors are emerging as novel and efficacious drugs for treating psoriasis and other inflammatory skin disorders, but their full potential is hampered by systemic side effects. To overcome this limitation, we set out to discover soft...

Cite
Ritzén A, Sørensen MD, Dack KN, et al. Fragment-Based Discovery of 6-Arylindazole JAK Inhibitors. ACS Med Chem Lett. 2016;7(6):641-6doi: 10.1021/acsmedchemlett.6b00087.
Ritzén, A., Sørensen, M. D., Dack, K. N., Greve, D. R., Jerre, A., Carnerup, M. A., Rytved, K. A., & Bagger-Bahnsen, J. (2016). Fragment-Based Discovery of 6-Arylindazole JAK Inhibitors. ACS medicinal chemistry letters, 7(6), 641-6. https://doi.org/10.1021/acsmedchemlett.6b00087
Ritzén, Andreas, et al. "Fragment-Based Discovery of 6-Arylindazole JAK Inhibitors." ACS medicinal chemistry letters vol. 7,6 (2016): 641-6. doi: https://doi.org/10.1021/acsmedchemlett.6b00087
Ritzén A, Sørensen MD, Dack KN, Greve DR, Jerre A, Carnerup MA, Rytved KA, Bagger-Bahnsen J. Fragment-Based Discovery of 6-Arylindazole JAK Inhibitors. ACS Med Chem Lett. 2016 Apr 14;7(6):641-6. doi: 10.1021/acsmedchemlett.6b00087. eCollection 2016 Jun 09. PMID: 27326341; PMCID: PMC4904270.
Copy Download .nbib Format: NLM
Continuous flow nucleophilic aromatic substitution with dimethylamine generated in situ by decomposition of DMF.

The Journal of organic chemistry

Petersen TP, Larsen AF, Ritzén A, Ulven T.
PMID: 23506299
J Org Chem. 2013 Apr 19;78(8):4190-5. doi: 10.1021/jo400390t. Epub 2013 Apr 02.

A safe, practical, and scalable continuous flow protocol for the in situ generation of dimethylamine from DMF followed by nucleophilic aromatic substitution of a broad range of aromatic and heteroaromatic halides is reported.

Cite
Petersen TP, Larsen AF, Ritzén A, et al. Continuous flow nucleophilic aromatic substitution with dimethylamine generated in situ by decomposition of DMF. J Org Chem. 2013;78(8):4190-5doi: 10.1021/jo400390t.
Petersen, T. P., Larsen, A. F., Ritzén, A., & Ulven, T. (2013). Continuous flow nucleophilic aromatic substitution with dimethylamine generated in situ by decomposition of DMF. The Journal of organic chemistry, 78(8), 4190-5. https://doi.org/10.1021/jo400390t
Petersen, Trine P, et al. "Continuous flow nucleophilic aromatic substitution with dimethylamine generated in situ by decomposition of DMF." The Journal of organic chemistry vol. 78,8 (2013): 4190-5. doi: https://doi.org/10.1021/jo400390t
Petersen TP, Larsen AF, Ritzén A, Ulven T. Continuous flow nucleophilic aromatic substitution with dimethylamine generated in situ by decomposition of DMF. J Org Chem. 2013 Apr 19;78(8):4190-5. doi: 10.1021/jo400390t. Epub 2013 Apr 02. PMID: 23506299.
Copy Download .nbib Format: NLM
Bioterrorism.

Journal of environmental health

Kortepeter MG, Cieslak TJ, Eitzen EM.
PMID: 11381472
J Environ Health. 2001 Jan-Feb;63(6):21-4.

Although biological agents have been used in warfare for centuries, several events in the past decade have raised concerns that they could be used for terrorism. Revelations about the sophisticated biological-weapons programs of the former Soviet Union and Iraq...

Cite
Kortepeter MG, Cieslak TJ, Eitzen EM. Bioterrorism. J Environ Health. 2001;63(6):21-4
Kortepeter, M. G., Cieslak, T. J., & Eitzen, E. M. (2001). Bioterrorism. Journal of environmental health, 63(6), 21-4.
Kortepeter, M G, et al. "Bioterrorism." Journal of environmental health vol. 63,6 (2001): 21-4.
Kortepeter MG, Cieslak TJ, Eitzen EM. Bioterrorism. J Environ Health. 2001 Jan-Feb;63(6):21-4. PMID: 11381472.
Copy Download .nbib Format: NLM
Prenatal treatment of congenital adrenal hyperplasia: a commentary.

Trends in endocrinology and metabolism: TEM

Ritzén EM.
PMID: 18406287
Trends Endocrinol Metab. 1998 Sep;9(7):293-5. doi: 10.1016/s1043-2760(98)00073-3.

No abstract available.

Cite
Ritzén EM. Prenatal treatment of congenital adrenal hyperplasia: a commentary. Trends Endocrinol Metab. 1998;9(7):293-5doi: 10.1016/s1043-2760(98)00073-3.
Ritzén, E. M. (1998). Prenatal treatment of congenital adrenal hyperplasia: a commentary. Trends in endocrinology and metabolism: TEM, 9(7), 293-5. https://doi.org/10.1016/s1043-2760(98)00073-3
Ritzén, E M. "Prenatal treatment of congenital adrenal hyperplasia: a commentary." Trends in endocrinology and metabolism: TEM vol. 9,7 (1998): 293-5. doi: https://doi.org/10.1016/s1043-2760(98)00073-3
Ritzén EM. Prenatal treatment of congenital adrenal hyperplasia: a commentary. Trends Endocrinol Metab. 1998 Sep;9(7):293-5. doi: 10.1016/s1043-2760(98)00073-3. PMID: 18406287.
Copy Download .nbib Format: NLM
Metabolic Effects of Growth Hormone Treatment in Short Prepubertal Children: A Double-Blinded Randomized Clinical Trial.

Hormone research in paediatrics

Tidblad A, Gustafsson J, Marcus C, Ritzén M, Ekström K.
PMID: 33684919
Horm Res Paediatr. 2020;93(9):519-528. doi: 10.1159/000513518. Epub 2021 Mar 08.

INTRODUCTION: Growth hormone (GH) is a central hormone for regulating linear growth during childhood and also highly involved in the metabolism of lipids, carbohydrates, and protein. However, few studies report on how treatment with GH during childhood influences metabolic...

Cite
Tidblad A, Gustafsson J, Marcus C, et al. Metabolic Effects of Growth Hormone Treatment in Short Prepubertal Children: A Double-Blinded Randomized Clinical Trial. Horm Res Paediatr. 2021;93(9):519-528doi: 10.1159/000513518.
Tidblad, A., Gustafsson, J., Marcus, C., Ritzén, M., & Ekström, K. (2020). Metabolic Effects of Growth Hormone Treatment in Short Prepubertal Children: A Double-Blinded Randomized Clinical Trial. Hormone research in paediatrics, 93(9), 519-528. https://doi.org/10.1159/000513518
Tidblad, Anders, et al. "Metabolic Effects of Growth Hormone Treatment in Short Prepubertal Children: A Double-Blinded Randomized Clinical Trial." Hormone research in paediatrics vol. 93,9 (2020): 519-528. doi: https://doi.org/10.1159/000513518
Tidblad A, Gustafsson J, Marcus C, Ritzén M, Ekström K. Metabolic Effects of Growth Hormone Treatment in Short Prepubertal Children: A Double-Blinded Randomized Clinical Trial. Horm Res Paediatr. 2020;93(9):519-528. doi: 10.1159/000513518. Epub 2021 Mar 08. PMID: 33684919.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 12 entries